Showing results (171-180 of 1,725) with videos related to
Sort By:
Pageof 173
Drugs of Today (Barcelona, Spain : 1998)|March 31, 2012
Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorderA C Childress, F R SalleeDrugs of Today (Barcelona, Spain : 1998)|February 22, 2012
Current therapies for nonalcoholic fatty liver diseaseA A Gossard, K D LindorDrugs of Today (Barcelona, Spain : 1998)|February 22, 2012
A report from the 47th European Association for the Study of Diabetes annual meeting (September 12-16, 2011 - Lisbon, Portugal)X RabassedaDrugs of Today (Barcelona, Spain : 1998)|April 20, 2012
The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disordersE Masliah, E Díez-TejedorDrugs of Today (Barcelona, Spain : 1998)|April 20, 2012
Cerebrolysin improves symptoms and delays progression in patients with Alzheimer's disease and vascular dementiaR F Allegri, A GuekhtDrugs of Today (Barcelona, Spain : 1998)|April 27, 2012
Brentuximab vedotin: its role in the treatment of anaplastic large cell and Hodgkin's lymphomaK HaddleyDrugs of Today (Barcelona, Spain : 1998)|March 23, 2012
[Sitagliptin in the treatment of type 2 diabetes: new data presented during the American Diabetes Association annual meeting (San Diego, California, June 2011)]X RabassedaDrugs of Today (Barcelona, Spain : 1998)|August 19, 2011
Rasburicase in cancer-related hyperuricemiaM Rodriguez, M Campara, Christina HaafDrugs of Today (Barcelona, Spain : 1998)|August 19, 2011
Interferon alfa and antiretroviral agents: a treatment option for adult T-cell leukemia/lymphomaKenji Ishitsuka, K Tsukasaki, K TamuraDrugs of Today (Barcelona, Spain : 1998)|September 16, 2011
[Musculoskeletal chronic pain: Latin-American expert panel review based on scientific evidence]J Angulo, R González, L Hernández, et al.Pageof 173